cystatin-c.blogspot.com
CYSTATIN C RESEARCH: February 2010
http://cystatin-c.blogspot.com/2010_02_01_archive.html
Cystatin C and Sudden Cardiac Death Risk in the Elderly. Conclusions: Impaired kidney function, as measured by cystatin C, has an independent association with SCD risk among elderly persons without clinical cardiovascular disease. Rajat Deo, MD; Nona Sotoodehnia, MD, MPH; Ronit Katz, DPhil; Mark J. Sarnak, MD, MS; Linda F. Fried, MD, MPH; Michel Chonchol, MD; Bryan Kestenbaum, MD; Bruce M. Psaty, MD, PhD; David S. Siscovick, MD, MPH and Michael G. Shlipak, MD, MPH. Posted by Diagnostic Research.
cystatin-c.blogspot.com
CYSTATIN C RESEARCH: Serum Cystatin C Is an Early Predictive Biomarker of Acute Kidney Injury after Pediatric Cardiopulmonary Bypass
http://cystatin-c.blogspot.com/2010/09/serum-cystatin-c-is-early-predictive.html
Serum Cystatin C Is an Early Predictive Biomarker of Acute Kidney Injury after Pediatric Cardiopulmonary Bypass. Results: One hundred nineteen patients (32%) developed AKI using SCr criteria. Serum cystatin C concentrations were significantly increased in AKI patients at 12 hours after CPB (P. Conclusion: Serum cystatin C is an early predictive biomarker for AKI and its clinical outcomes after pediatric CPB. Posted by Diagnostic Research. Subscribe to: Post Comments (Atom). Cystatin Monomer and Dimer.
cystatin-c.blogspot.com
CYSTATIN C RESEARCH: November 2011
http://cystatin-c.blogspot.com/2011_11_01_archive.html
Cystatin C Level as a Predictor of Death and Cardiovascular Events After Liver Transplantation. Clinical and biochemical data, including Cys levels, were analyzed in 99 cirrhotic candidates for OLT. We recorded cardiovascular events. Receiver-operator characteristics curves showed a similar efficiency to detect a creatinine clearance. 1400 ng/mL before OLT, showing a significant difference (P. Volume 43, Issue 3, April 2011, Pages 732-734. Posted by Diagnostic Research. Links to this post.
cystatin-c.blogspot.com
CYSTATIN C RESEARCH: April 2011
http://cystatin-c.blogspot.com/2011_04_01_archive.html
Cystatin C, a marker for successful aging and glomerular filtration rate, is not influenced by inflammation. Methods. Cystatin C, creatinine, and the inflammatory markers CRP, serum amyloid A (SAA), haptoglobin and orosomucoid were measured in plasma samples from 35 patients the day before elective surgery and subsequently during seven consecutive days. Conclusion. The inflammatory status of a patient does not influence the role of cystatin C as a marker of successful aging, nor of GFR. Links to this post.
humanafp.blogspot.com
Alpha FetoProtein and other Newborn Research: Immunohistochemistry is an Essential Diagnostic Tool for Children With Hepatic Tumors and Low Alpha Fetoprotein
http://humanafp.blogspot.com/2010/01/immunohistochemistry-is-essential.html
Alpha FetoProtein and other Newborn Research. Current Reseach on newborns with Birth Defects and Human Alpha Fetoprotein Research. Immunohistochemistry is an Essential Diagnostic Tool for Children With Hepatic Tumors and Low Alpha Fetoprotein. Journal of Pediatric Hematology/Oncology:. POST AUTHOR CORRECTIONS, 30 December 2009. Posted by Clinical Diagnostic Research. Beta 2 Microglobulin Research. Standford School Of Medicine. Geveva Foundation for Medical Research. Lee Biosolutions, Inc.
humanafp.blogspot.com
Alpha FetoProtein and other Newborn Research: Level of α-fetoprotein predicts mortality among patients with hepatitis C-related hepatocellular carcinoma.
http://humanafp.blogspot.com/2011/12/level-of-fetoprotein-predicts-mortality.html
Alpha FetoProtein and other Newborn Research. Current Reseach on newborns with Birth Defects and Human Alpha Fetoprotein Research. Level of α-fetoprotein predicts mortality among patients with hepatitis C-related hepatocellular carcinoma. CONCLUSIONS: Serum AFP level at the time of diagnosis with HCV-related HCC is an independent predictor of mortality. REF: Clin Gastroenterol Hepatol. 2011 Nov;9(11):989-94. Epub 2011 Aug 4. Posted by Clinical Diagnostic Research. Beta 2 Microglobulin Research.
humanafp.blogspot.com
Alpha FetoProtein and other Newborn Research: Targeting alpha-fetoprotein represses the proliferation of hepatoma cells via regulation of the cell cycle
http://humanafp.blogspot.com/2008/07/targeting-alpha-fetoprotein-represses.html
Alpha FetoProtein and other Newborn Research. Current Reseach on newborns with Birth Defects and Human Alpha Fetoprotein Research. Targeting alpha-fetoprotein represses the proliferation of hepatoma cells via regulation of the cell cycle. Is a biomarker for primary liver cancer, yet little is known about its effect in the pathogenesis of hepatoma. We examined how AFP modulates the proliferation of hepatoma cells. Recombinant adenovirus expressing siRNA against alpha fetoprotein (AFP). Is a critical deter...
cystatin-c.blogspot.com
CYSTATIN C RESEARCH: January 2009
http://cystatin-c.blogspot.com/2009_01_01_archive.html
Interruption of antiretroviral therapy is associated with increased plasma cystatin C. AIDS 23(1):71-82, January 2, 2009. Mocroft, Amanda a; Wyatt, Christina b; Szczech, Lynda c; Neuhaus, Jacquie d; El-Sadr, Wafaa e; Tracy, Russell f; Kuller, Lewis g; Shlipak, Michael h; Angus, Brian i,j; Klinker, Harting k; Ross, Michael b;. Conclusion: These results demonstrate that interruption of antiretroviral therapy is associated with an increase in cystatin C, which may reflect worsened renal function. Lung Unive...
cystatin-c.blogspot.com
CYSTATIN C RESEARCH: Urinary cystatin C prognostic marker in acute kidney injury
http://cystatin-c.blogspot.com/2013/06/urinary-cystatin-c-prognostic-marker-in.html
Urinary cystatin C prognostic marker in acute kidney injury. By Sally Robertson, medwireNews Reporter. UCysC) level may be a useful biomarker for discriminating between prerenal and intrinsic acute kidney injury (AKI), report researchers. Our findings may assist physicians when making therapeutic decisions regarding patients with AKI," remark Jin Kuk Kim (Soonchunhyang University Hospital, Bucheon, Korea) and colleagues. In a study of 213 patients presenting with acute kidney disease, uCysC. The team per...